IMC1C11
chimeric anti-kinase insert domain-containing receptor (KDR) antibody that blocks VEGFR-KDR interaction and inhibits VEGFR-induced endothelial cell proliferation; used for treatment of patients with liver metastases from colorectal carcinoma (in Phase I trial 1/2004)
Networked: 4
relevant articles (0 outcomes,
1 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Dias, S:
2 articles
(03/2003 - 08/2000)
|
2. | Hattori, K:
2 articles
(03/2003 - 08/2000)
|
3. | Rafii, S:
2 articles
(03/2003 - 08/2000)
|
4. | Witte, L:
2 articles
(03/2003 - 08/2000)
|
5. | Zhu, Z:
2 articles
(03/2003 - 08/2000)
|
6. | Hicklin, Daniel J:
1 article
(11/2004)
|
7. | Moore, Malcolm A S:
1 article
(11/2004)
|
8. | Teruya-Feldstein, Julie:
1 article
(11/2004)
|
9. | Wang, Eunice S:
1 article
(11/2004)
|
10. | Wu, Yan:
1 article
(11/2004)
|
Related Diseases
Related Drugs and Biologics